Aug 28, 2012

Farmak JSC begins marketing Sinarta, a drug to treat osteoarthritis

Farmak JSC has expanded the range of chondroprotectors by launching Sinarta, a glucosamine sulfate drug that comes as a solution for injection. This medication has augmented the portfolio of drugs which rheumatologists, traumatologists, and neurologists may use to treat inflammatory and degenerative diseases of the musculoskeletal system.

Sinarta is the first generic glucosamine sulfate injection drug in Ukraine. It comes as a solution for intramuscular administration.

Sinarta is produced in the form of solution for injection: 5 ampoules with active substance and 5 ampoules with solvent per package.


Back to the News